CureVac's total assets for Q3 2024 were €854.19M, an increase of 53.40% from the previous quarter. DE:5CV total liabilities were €129.49M for the fiscal quarter, a -28.18% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.